Lixte Biotech Hlds
(LIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,039 | 4,204 | 5,353 | 4,824 | 5,069 |
| Other current assets | 0 | 78 | 147 | 150 | 77 |
| TOTAL | $1,146 | $4,309 | $5,561 | $5,093 | $5,229 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $1,146 | $4,309 | $5,561 | $5,093 | $5,229 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 83 | 157 | 231 | 226 | 190 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 11 |
| Other current liabilities | 235 | 157 | 165 | 77 | 16 |
| TOTAL | $318 | $314 | $396 | $303 | $217 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $318 | $314 | $396 | $303 | $217 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,684 | 2,249 | 1,666 | 1,375 | 1,354 |
| Common Shares | 0 | 0 | 0 | 1 | 1 |
| Retained earnings | -52,068 | -48,482 | -43,395 | -37,082 | -30,354 |
| TOTAL | $827 | $3,995 | $5,165 | $4,790 | $5,012 |
| Total Liabilities And Equity | $1,146 | $4,309 | $5,561 | $5,093 | $5,229 |